Key Highlights
- Adjusted diluted EPS of USD 3.63 topped the consensus estimate of USD 3.59 and rose 18% from a year earlier.
- Revenue of USD 2.46 billion grew from USD 2.29 billion and landed above the consensus estimate of USD 2.45 billion.
- Adjusted Operating Margin reached 21.9%, up 150 basis points, or 100 excluding a USD 13 million property sale gain.
- Organic Revenue grew 4% overall, with Risk and Broking up 5%, while Benefits Delivery and Outsourcing declined 2%.
Willis Towers Watson Public Limited Company (NASDAQ:WTW) reported third quarter 2026 adjusted Diluted Earnings per Share of USD 3.63, above the consensus estimate of USD 3.59, while GAAP diluted EPS was USD 3.24 compared with USD 3.11 a year earlier. Total revenue of USD 2,460 million rose from USD 2,288 million and exceeded the consensus estimate of USD 2.45 billion. Net Income attributable to the company was USD 303 million, little changed from USD 304 million, as higher interest expense and losses from associates offset stronger Operating Income of USD 429 million.
Segment Growth and the Margin Bridge
Chief Executive Officer Carl Hess pointed to 4% organic growth and 150 basis points of adjusted operating margin expansion. Health, Wealth and Career grew 4% organically, with Health up 6%, Wealth up 2% and Career up 9%, while Benefits Delivery and Outsourcing slipped 2% as several large individual marketplace clients pushed implementations into next year. The segment margin was 29.5%, up 90 basis points.
Risk and Broking organic revenue rose 5%, or 4% excluding book of Business settlements and interest income, and its margin improved 100 basis points to 19.8%. The company added that a USD 13 million gain on the sale of office buildings contributed about USD 0.11 to adjusted EPS, offset by lower interest income and a larger loss from the Willis Re Equity method investment. Insurance Consulting and Technology grew 2%.
Guidance Adjustments and the Propel Program
Management kept its full year targets of mid single digit organic growth, though toward the lower end of that range, and about 100 basis points of margin expansion. Health, Wealth and Career growth is now projected at low to mid single digits, down from mid single digits, with Benefits Delivery and Outsourcing revenue roughly flat and Career narrowed to low single digits. Foreign currency is a USD 0.02 tailwind to fourth quarter adjusted EPS and USD 0.35 for the full year.
The Propel AI acceleration plan targets about USD 400 million of run rate savings by the end of 2028 on roughly USD 625 million of cash investment, leaving about USD 350 million net after reinvestment and an adjusted operating margin near 30% in 2028. In the third quarter the company incurred about USD 7 million of cash costs and USD 14 million of non cash charges, with annualized run rate savings so far near USD 18 million.
Fourth Quarter Items Worth Tracking
Several dated items stand out. The first global release of the Neuron AI operating model in Risk and Broking is scheduled for the fourth quarter and reaches 10 additional countries. Willis Re, the Reinsurance joint venture with Bain Capital, has an agreement to acquire the BMS Re U.S. reinsurance broking business, targeted to close in the fourth quarter pending regulatory approval.
Capital returns also bear watching. The company repurchased USD 220 million of shares in the quarter and USD 970 million year to date against a USD 1 billion full year plan, now projected to be exceeded, and paid USD 89 million of dividends. Nine month free Cash Flow was USD 1.064 billion versus USD 838 million, and management said Risk and Broking seasonality makes the fourth quarter its highest margin period.






Please wait processing your request...